Oragenics Inc (NYSEAMERICAN:OGEN)’s share price crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.00 and traded as low as $0.48. Oragenics shares last traded at $0.48, with a volume of 200 shares traded.
Separately, HC Wainwright lifted their price target on Orion Energy Systems from $1.75 to $3.75 and gave the stock a “buy” rating in a report on Tuesday, May 21st.
Oragenics (NYSEAMERICAN:OGEN) last posted its quarterly earnings results on Monday, May 13th. The biotechnology company reported ($0.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.03).
An institutional investor recently raised its position in Oragenics stock. BlackRock Inc. raised its position in shares of Oragenics Inc (NYSEAMERICAN:OGEN) by 82,549.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 705,824 shares of the biotechnology company’s stock after acquiring an additional 704,970 shares during the period. BlackRock Inc. owned approximately 2.40% of Oragenics worth $606,000 at the end of the most recent quarter.
Oragenics Company Profile (NYSEAMERICAN:OGEN)
Oragenics, Inc develops novel antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients.
Further Reading: Penny Stocks
Receive News & Ratings for Oragenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oragenics and related companies with MarketBeat.com's FREE daily email newsletter.